1 / 6

Immune Thrombocytopenia (ITP) Market Growth rate, Shares and Forecasts to 2027

The global Immune thrombocytopenia market was valued at USD 2.18 billion in 2019 and is expected to reach USD 3.68 billion by the year 2027, at a CAGR of 6.7%

VijayKurane
Download Presentation

Immune Thrombocytopenia (ITP) Market Growth rate, Shares and Forecasts to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immune Thrombocytopenia (ITP) Market To Reach USD 3.68 Billion By 2027 www.reportsanddata.com

  2. Market Summary Market Size – USD 2.18 billion in 2019, Market Growth - CAGR of 6.7%, Market Trends – Growing demand for combination therapies, rising concern towards rare diseases, increased R&D investments are drivers leading to the growth of Immune thrombocytopenia Market. The global Immune thrombocytopenia market was valued at USD 2.18 billion in 2019 and is expected to reach USD 3.68 billion by the year 2027, at a CAGR of 6.7%. The global Immune thrombocytopenia market is growing at a substantial pace owing to the growing demand therapy for rare diseases such as immune thrombocytopenia, favorable government initiatives taken up by the authorities, availability of financial support for research and development. • Further key findings from the report suggest • The North America Immune thrombocytopenia market is anticipated to dominate the in the global market. The major driving factors for the growth of this market are rising awareness about the disease and favourable research funding scenario and government initiatives, and high medical reimbursement facilities. • Based on product segment, corticosteroids are expected to have the largest market share among the other segments during the forecast period. This is attributed to the widespread application of corticosteroids to effectively influence healthcare outcomes. Moreover, it is most common form of treatment owing to its potential benefits. www.reportsanddata.com

  3. Market Summary Key Players: Hoffman-L Roche, Novartis, GlaxoSmithKline, Eisai, Amgen, GrifolsBiologicals Inc., Contract Pharmacal, Baxter, CSL Behring, Bristol-Myers Squibb, Roxane, and others. Segmentation: Products Outlook (Revenue, USD million; 2017-2027) Corticosteroids Intravenous Immunoglobulin (IVIG) Anti-D Immunoglobulin Spleen tyrosine kinase inhibitor Rho (D) immunoglobulin intravenous Thrombopoietin Receptor Agonists (TPO-RA) General immunosuppressants Antibiotics Hormone therapy Splenectomy Others www.reportsanddata.com Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3401

  4. Market Summary Type Outlook (Revenue, USD million; 2017-2027) Acute Chronic End Use Outlook (Revenue, USD million; 2017-2027) Hospitals and clinics Research Organisation Others Regional Outlook for Immune Thrombocytopenia (ITP) Market analyses the following geographies: North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) www.reportsanddata.com Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3401

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com www.reportsanddata.com

More Related